Manufacturer
Pfizer Italia S.r.l.
Contents
Voriconazole
Indication
Invasive aspergillosis; fluconazole-resistant serious invasive Candida infections (eg, C krusei); serious Candida infections eg, esophageal candidiasis; candidemia in non-neutropenic patients & the following Candida infections: Disseminated infection in skin & abdomen, kidney, bladder wall & wounds; fungal infections caused by Scedosporium spp & Fusarium spp. Prevention of breakthrough fungal infections in febrile high-risk neutropenic patients; prophylaxis in patients ≥12 yr at high risk of developing invasive fungal infections.
Instruction
Should be taken on an empty stomach: Take at least 1 hr before or after meals.
Drug interaction
Terfenadine, astemizole, cisapride, pimozide, quinidine, sirolimus, rifampicin, ritonavir, carbamazepine, phenobarb, efavirenz, ergotamine, dihydroergotamine, rifabutin, St. John's wort. Phenytoin, cyclosporine, tacrolimus, methadone, fentanyl, oxycodone, warfarin & other coumarins, sulfonylureas, statins, benzodiazepines, vinca alkaloids, NSAIDs, omeprazole, OC, HIV PIs, NNRTIs.
Malaysia
